nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitotane—SHBG—prostate cancer	0.32	1	CbGaD
Mitotane—SHBG—Estrone—prostate cancer	0.151	0.405	CbGbCtD
Mitotane—SHBG—Ethinyl Estradiol—prostate cancer	0.134	0.361	CbGbCtD
Mitotane—SHBG—Estradiol—prostate cancer	0.0867	0.233	CbGbCtD
Mitotane—SHBG—semen—prostate cancer	0.00751	0.194	CbGeAlD
Mitotane—FDX1—prostate gland—prostate cancer	0.00517	0.133	CbGeAlD
Mitotane—FDX1—seminal vesicle—prostate cancer	0.00438	0.113	CbGeAlD
Mitotane—FDX1—renal system—prostate cancer	0.00353	0.0909	CbGeAlD
Mitotane—FDX1—urethra—prostate cancer	0.00346	0.0893	CbGeAlD
Mitotane—FDX1—bone marrow—prostate cancer	0.00267	0.0687	CbGeAlD
Mitotane—FDX1—testis—prostate cancer	0.00228	0.0587	CbGeAlD
Mitotane—SHBG—prostate gland—prostate cancer	0.00188	0.0486	CbGeAlD
Mitotane—FDX1—lymph node—prostate cancer	0.00165	0.0426	CbGeAlD
Mitotane—SERPINA6—renal system—prostate cancer	0.00152	0.0393	CbGeAlD
Mitotane—SERPINA6—bone marrow—prostate cancer	0.00115	0.0297	CbGeAlD
Mitotane—CYP11A1—testis—prostate cancer	0.00104	0.0267	CbGeAlD
Mitotane—SHBG—bone marrow—prostate cancer	0.000971	0.025	CbGeAlD
Mitotane—SHBG—testis—prostate cancer	0.00083	0.0214	CbGeAlD
Mitotane—CYP11A1—lymph node—prostate cancer	0.00075	0.0193	CbGeAlD
Mitotane—Econazole—CYP17A1—prostate cancer	0.000732	0.292	CrCbGaD
Mitotane—Econazole—CYP19A1—prostate cancer	0.000372	0.148	CrCbGaD
Mitotane—Econazole—CYP2E1—prostate cancer	0.000278	0.111	CrCbGaD
Mitotane—Chlorphenamine—SLC22A1—prostate cancer	0.000247	0.0983	CrCbGaD
Mitotane—Chlorphenamine—CYP3A5—prostate cancer	0.000199	0.0793	CrCbGaD
Mitotane—Econazole—CYP3A4—prostate cancer	0.000175	0.0697	CrCbGaD
Mitotane—Carbinoxamine—CYP2E1—prostate cancer	0.000161	0.0641	CrCbGaD
Mitotane—Carbinoxamine—CYP2C19—prostate cancer	0.000159	0.0635	CrCbGaD
Mitotane—Carbinoxamine—CYP3A4—prostate cancer	0.000101	0.0404	CrCbGaD
Mitotane—Chlorphenamine—CYP3A4—prostate cancer	8.61e-05	0.0343	CrCbGaD
Mitotane—Orthostatic hypotension—Epirubicin—prostate cancer	7.85e-05	0.000581	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	7.81e-05	0.000578	CcSEcCtD
Mitotane—Vomiting—Goserelin—prostate cancer	7.8e-05	0.000577	CcSEcCtD
Mitotane—Breast disorder—Epirubicin—prostate cancer	7.77e-05	0.000575	CcSEcCtD
Mitotane—Pain—Mitoxantrone—prostate cancer	7.75e-05	0.000573	CcSEcCtD
Mitotane—Angiopathy—Capecitabine—prostate cancer	7.74e-05	0.000573	CcSEcCtD
Mitotane—Rash—Goserelin—prostate cancer	7.73e-05	0.000572	CcSEcCtD
Mitotane—Dermatitis—Goserelin—prostate cancer	7.73e-05	0.000572	CcSEcCtD
Mitotane—Vomiting—Conjugated Estrogens—prostate cancer	7.72e-05	0.000571	CcSEcCtD
Mitotane—Mental disorder—Docetaxel—prostate cancer	7.72e-05	0.000571	CcSEcCtD
Mitotane—Body temperature increased—Estradiol—prostate cancer	7.69e-05	0.000569	CcSEcCtD
Mitotane—Headache—Goserelin—prostate cancer	7.68e-05	0.000568	CcSEcCtD
Mitotane—Malnutrition—Docetaxel—prostate cancer	7.67e-05	0.000568	CcSEcCtD
Mitotane—Rash—Conjugated Estrogens—prostate cancer	7.66e-05	0.000567	CcSEcCtD
Mitotane—Dermatitis—Conjugated Estrogens—prostate cancer	7.65e-05	0.000566	CcSEcCtD
Mitotane—Headache—Conjugated Estrogens—prostate cancer	7.61e-05	0.000563	CcSEcCtD
Mitotane—Confusional state—Etoposide—prostate cancer	7.6e-05	0.000562	CcSEcCtD
Mitotane—Muscular weakness—Epirubicin—prostate cancer	7.58e-05	0.000561	CcSEcCtD
Mitotane—Dysgeusia—Docetaxel—prostate cancer	7.51e-05	0.000556	CcSEcCtD
Mitotane—Infection—Etoposide—prostate cancer	7.49e-05	0.000554	CcSEcCtD
Mitotane—Ataxia—Doxorubicin—prostate cancer	7.48e-05	0.000553	CcSEcCtD
Mitotane—Mental disorder—Capecitabine—prostate cancer	7.48e-05	0.000553	CcSEcCtD
Mitotane—Connective tissue disorder—Prednisone—prostate cancer	7.47e-05	0.000553	CcSEcCtD
Mitotane—Feeling abnormal—Mitoxantrone—prostate cancer	7.47e-05	0.000552	CcSEcCtD
Mitotane—Malnutrition—Capecitabine—prostate cancer	7.43e-05	0.00055	CcSEcCtD
Mitotane—Thrombocytopenia—Etoposide—prostate cancer	7.38e-05	0.000546	CcSEcCtD
Mitotane—Skin disorder—Etoposide—prostate cancer	7.32e-05	0.000542	CcSEcCtD
Mitotane—Nausea—Goserelin—prostate cancer	7.29e-05	0.000539	CcSEcCtD
Mitotane—Dysgeusia—Capecitabine—prostate cancer	7.28e-05	0.000538	CcSEcCtD
Mitotane—Orthostatic hypotension—Doxorubicin—prostate cancer	7.26e-05	0.000537	CcSEcCtD
Mitotane—Nausea—Conjugated Estrogens—prostate cancer	7.22e-05	0.000534	CcSEcCtD
Mitotane—Breast disorder—Doxorubicin—prostate cancer	7.19e-05	0.000532	CcSEcCtD
Mitotane—Anorexia—Etoposide—prostate cancer	7.18e-05	0.000531	CcSEcCtD
Mitotane—Hypersensitivity—Estradiol—prostate cancer	7.16e-05	0.00053	CcSEcCtD
Mitotane—Body temperature increased—Mitoxantrone—prostate cancer	7.16e-05	0.00053	CcSEcCtD
Mitotane—Eye disorder—Prednisone—prostate cancer	7.1e-05	0.000526	CcSEcCtD
Mitotane—Anaemia—Docetaxel—prostate cancer	7.09e-05	0.000525	CcSEcCtD
Mitotane—Flushing—Prednisone—prostate cancer	7.06e-05	0.000522	CcSEcCtD
Mitotane—Hypotension—Etoposide—prostate cancer	7.04e-05	0.000521	CcSEcCtD
Mitotane—Muscular weakness—Doxorubicin—prostate cancer	7.01e-05	0.000519	CcSEcCtD
Mitotane—Vision blurred—Capecitabine—prostate cancer	7e-05	0.000518	CcSEcCtD
Mitotane—Asthenia—Estradiol—prostate cancer	6.98e-05	0.000516	CcSEcCtD
Mitotane—Tremor—Capecitabine—prostate cancer	6.96e-05	0.000515	CcSEcCtD
Mitotane—Neutropenia—Epirubicin—prostate cancer	6.95e-05	0.000514	CcSEcCtD
Mitotane—Angiopathy—Prednisone—prostate cancer	6.9e-05	0.00051	CcSEcCtD
Mitotane—Anaemia—Capecitabine—prostate cancer	6.87e-05	0.000508	CcSEcCtD
Mitotane—Paraesthesia—Etoposide—prostate cancer	6.77e-05	0.000501	CcSEcCtD
Mitotane—Somnolence—Etoposide—prostate cancer	6.7e-05	0.000496	CcSEcCtD
Mitotane—Vertigo—Capecitabine—prostate cancer	6.68e-05	0.000494	CcSEcCtD
Mitotane—Hypersensitivity—Mitoxantrone—prostate cancer	6.67e-05	0.000494	CcSEcCtD
Mitotane—Mental disorder—Prednisone—prostate cancer	6.66e-05	0.000493	CcSEcCtD
Mitotane—Diarrhoea—Estradiol—prostate cancer	6.65e-05	0.000492	CcSEcCtD
Mitotane—Hypertension—Docetaxel—prostate cancer	6.63e-05	0.00049	CcSEcCtD
Mitotane—Drowsiness—Epirubicin—prostate cancer	6.62e-05	0.00049	CcSEcCtD
Mitotane—Infestation—Epirubicin—prostate cancer	6.62e-05	0.00049	CcSEcCtD
Mitotane—Infestation NOS—Epirubicin—prostate cancer	6.62e-05	0.00049	CcSEcCtD
Mitotane—Malnutrition—Prednisone—prostate cancer	6.62e-05	0.00049	CcSEcCtD
Mitotane—Decreased appetite—Etoposide—prostate cancer	6.55e-05	0.000485	CcSEcCtD
Mitotane—Gastrointestinal disorder—Etoposide—prostate cancer	6.51e-05	0.000481	CcSEcCtD
Mitotane—Asthenia—Mitoxantrone—prostate cancer	6.5e-05	0.000481	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	6.49e-05	0.00048	CcSEcCtD
Mitotane—Pain—Etoposide—prostate cancer	6.44e-05	0.000477	CcSEcCtD
Mitotane—Dizziness—Estradiol—prostate cancer	6.43e-05	0.000476	CcSEcCtD
Mitotane—Neutropenia—Doxorubicin—prostate cancer	6.43e-05	0.000475	CcSEcCtD
Mitotane—Hypertension—Capecitabine—prostate cancer	6.41e-05	0.000475	CcSEcCtD
Mitotane—Haematuria—Epirubicin—prostate cancer	6.32e-05	0.000467	CcSEcCtD
Mitotane—Confusional state—Docetaxel—prostate cancer	6.31e-05	0.000467	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	6.28e-05	0.000465	CcSEcCtD
Mitotane—Hepatobiliary disease—Epirubicin—prostate cancer	6.26e-05	0.000463	CcSEcCtD
Mitotane—Vision blurred—Prednisone—prostate cancer	6.24e-05	0.000461	CcSEcCtD
Mitotane—Infection—Docetaxel—prostate cancer	6.22e-05	0.00046	CcSEcCtD
Mitotane—Feeling abnormal—Etoposide—prostate cancer	6.21e-05	0.000459	CcSEcCtD
Mitotane—Diarrhoea—Mitoxantrone—prostate cancer	6.2e-05	0.000459	CcSEcCtD
Mitotane—Vomiting—Estradiol—prostate cancer	6.18e-05	0.000457	CcSEcCtD
Mitotane—Shock—Docetaxel—prostate cancer	6.16e-05	0.000456	CcSEcCtD
Mitotane—Nervous system disorder—Docetaxel—prostate cancer	6.14e-05	0.000454	CcSEcCtD
Mitotane—Thrombocytopenia—Docetaxel—prostate cancer	6.13e-05	0.000454	CcSEcCtD
Mitotane—Rash—Estradiol—prostate cancer	6.13e-05	0.000454	CcSEcCtD
Mitotane—Drowsiness—Doxorubicin—prostate cancer	6.13e-05	0.000453	CcSEcCtD
Mitotane—Infestation—Doxorubicin—prostate cancer	6.13e-05	0.000453	CcSEcCtD
Mitotane—Infestation NOS—Doxorubicin—prostate cancer	6.13e-05	0.000453	CcSEcCtD
Mitotane—Dermatitis—Estradiol—prostate cancer	6.13e-05	0.000453	CcSEcCtD
Mitotane—Anaemia—Prednisone—prostate cancer	6.12e-05	0.000453	CcSEcCtD
Mitotane—Confusional state—Capecitabine—prostate cancer	6.11e-05	0.000452	CcSEcCtD
Mitotane—Headache—Estradiol—prostate cancer	6.09e-05	0.000451	CcSEcCtD
Mitotane—Skin disorder—Docetaxel—prostate cancer	6.08e-05	0.00045	CcSEcCtD
Mitotane—Infection—Capecitabine—prostate cancer	6.02e-05	0.000446	CcSEcCtD
Mitotane—Anorexia—Docetaxel—prostate cancer	5.97e-05	0.000442	CcSEcCtD
Mitotane—Shock—Capecitabine—prostate cancer	5.97e-05	0.000441	CcSEcCtD
Mitotane—Body temperature increased—Etoposide—prostate cancer	5.96e-05	0.000441	CcSEcCtD
Mitotane—Nervous system disorder—Capecitabine—prostate cancer	5.95e-05	0.00044	CcSEcCtD
Mitotane—Vertigo—Prednisone—prostate cancer	5.95e-05	0.00044	CcSEcCtD
Mitotane—Hepatitis—Epirubicin—prostate cancer	5.95e-05	0.00044	CcSEcCtD
Mitotane—Thrombocytopenia—Capecitabine—prostate cancer	5.94e-05	0.000439	CcSEcCtD
Mitotane—Skin disorder—Capecitabine—prostate cancer	5.89e-05	0.000436	CcSEcCtD
Mitotane—Urinary tract disorder—Epirubicin—prostate cancer	5.87e-05	0.000434	CcSEcCtD
Mitotane—Hypotension—Docetaxel—prostate cancer	5.85e-05	0.000433	CcSEcCtD
Mitotane—Haematuria—Doxorubicin—prostate cancer	5.84e-05	0.000432	CcSEcCtD
Mitotane—Connective tissue disorder—Epirubicin—prostate cancer	5.84e-05	0.000432	CcSEcCtD
Mitotane—Urethral disorder—Epirubicin—prostate cancer	5.83e-05	0.000431	CcSEcCtD
Mitotane—Hepatobiliary disease—Doxorubicin—prostate cancer	5.8e-05	0.000429	CcSEcCtD
Mitotane—Anorexia—Capecitabine—prostate cancer	5.78e-05	0.000428	CcSEcCtD
Mitotane—Nausea—Estradiol—prostate cancer	5.78e-05	0.000427	CcSEcCtD
Mitotane—Vomiting—Mitoxantrone—prostate cancer	5.76e-05	0.000426	CcSEcCtD
Mitotane—Visual impairment—Epirubicin—prostate cancer	5.73e-05	0.000424	CcSEcCtD
Mitotane—Hypertension—Prednisone—prostate cancer	5.71e-05	0.000423	CcSEcCtD
Mitotane—Rash—Mitoxantrone—prostate cancer	5.71e-05	0.000423	CcSEcCtD
Mitotane—Dermatitis—Mitoxantrone—prostate cancer	5.71e-05	0.000422	CcSEcCtD
Mitotane—Headache—Mitoxantrone—prostate cancer	5.68e-05	0.00042	CcSEcCtD
Mitotane—Hypotension—Capecitabine—prostate cancer	5.67e-05	0.000419	CcSEcCtD
Mitotane—Paraesthesia—Docetaxel—prostate cancer	5.62e-05	0.000416	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	5.6e-05	0.000414	CcSEcCtD
Mitotane—Somnolence—Docetaxel—prostate cancer	5.57e-05	0.000412	CcSEcCtD
Mitotane—Eye disorder—Epirubicin—prostate cancer	5.56e-05	0.000411	CcSEcCtD
Mitotane—Hypersensitivity—Etoposide—prostate cancer	5.55e-05	0.000411	CcSEcCtD
Mitotane—Flushing—Epirubicin—prostate cancer	5.52e-05	0.000408	CcSEcCtD
Mitotane—Dyspepsia—Docetaxel—prostate cancer	5.51e-05	0.000408	CcSEcCtD
Mitotane—Hepatitis—Doxorubicin—prostate cancer	5.5e-05	0.000407	CcSEcCtD
Mitotane—Paraesthesia—Capecitabine—prostate cancer	5.44e-05	0.000403	CcSEcCtD
Mitotane—Decreased appetite—Docetaxel—prostate cancer	5.44e-05	0.000403	CcSEcCtD
Mitotane—Urinary tract disorder—Doxorubicin—prostate cancer	5.43e-05	0.000402	CcSEcCtD
Mitotane—Gastrointestinal disorder—Docetaxel—prostate cancer	5.41e-05	0.0004	CcSEcCtD
Mitotane—Asthenia—Etoposide—prostate cancer	5.41e-05	0.0004	CcSEcCtD
Mitotane—Connective tissue disorder—Doxorubicin—prostate cancer	5.41e-05	0.0004	CcSEcCtD
Mitotane—Angiopathy—Epirubicin—prostate cancer	5.39e-05	0.000399	CcSEcCtD
Mitotane—Urethral disorder—Doxorubicin—prostate cancer	5.39e-05	0.000399	CcSEcCtD
Mitotane—Nausea—Mitoxantrone—prostate cancer	5.38e-05	0.000398	CcSEcCtD
Mitotane—Infection—Prednisone—prostate cancer	5.37e-05	0.000397	CcSEcCtD
Mitotane—Pain—Docetaxel—prostate cancer	5.36e-05	0.000396	CcSEcCtD
Mitotane—Dyspepsia—Capecitabine—prostate cancer	5.34e-05	0.000395	CcSEcCtD
Mitotane—Shock—Prednisone—prostate cancer	5.31e-05	0.000393	CcSEcCtD
Mitotane—Visual impairment—Doxorubicin—prostate cancer	5.3e-05	0.000392	CcSEcCtD
Mitotane—Nervous system disorder—Prednisone—prostate cancer	5.3e-05	0.000392	CcSEcCtD
Mitotane—Decreased appetite—Capecitabine—prostate cancer	5.27e-05	0.00039	CcSEcCtD
Mitotane—Skin disorder—Prednisone—prostate cancer	5.25e-05	0.000388	CcSEcCtD
Mitotane—Gastrointestinal disorder—Capecitabine—prostate cancer	5.23e-05	0.000387	CcSEcCtD
Mitotane—Mental disorder—Epirubicin—prostate cancer	5.21e-05	0.000385	CcSEcCtD
Mitotane—Pain—Capecitabine—prostate cancer	5.19e-05	0.000384	CcSEcCtD
Mitotane—Malnutrition—Epirubicin—prostate cancer	5.18e-05	0.000383	CcSEcCtD
Mitotane—Feeling abnormal—Docetaxel—prostate cancer	5.16e-05	0.000382	CcSEcCtD
Mitotane—Diarrhoea—Etoposide—prostate cancer	5.16e-05	0.000381	CcSEcCtD
Mitotane—Anorexia—Prednisone—prostate cancer	5.15e-05	0.000381	CcSEcCtD
Mitotane—Eye disorder—Doxorubicin—prostate cancer	5.14e-05	0.00038	CcSEcCtD
Mitotane—Flushing—Doxorubicin—prostate cancer	5.11e-05	0.000378	CcSEcCtD
Mitotane—Dysgeusia—Epirubicin—prostate cancer	5.07e-05	0.000375	CcSEcCtD
Mitotane—Feeling abnormal—Capecitabine—prostate cancer	5e-05	0.00037	CcSEcCtD
Mitotane—Angiopathy—Doxorubicin—prostate cancer	4.99e-05	0.000369	CcSEcCtD
Mitotane—Dizziness—Etoposide—prostate cancer	4.98e-05	0.000369	CcSEcCtD
Mitotane—Body temperature increased—Docetaxel—prostate cancer	4.95e-05	0.000366	CcSEcCtD
Mitotane—Vision blurred—Epirubicin—prostate cancer	4.88e-05	0.000361	CcSEcCtD
Mitotane—Paraesthesia—Prednisone—prostate cancer	4.85e-05	0.000359	CcSEcCtD
Mitotane—Mental disorder—Doxorubicin—prostate cancer	4.82e-05	0.000357	CcSEcCtD
Mitotane—Body temperature increased—Capecitabine—prostate cancer	4.79e-05	0.000355	CcSEcCtD
Mitotane—Vomiting—Etoposide—prostate cancer	4.79e-05	0.000354	CcSEcCtD
Mitotane—Malnutrition—Doxorubicin—prostate cancer	4.79e-05	0.000354	CcSEcCtD
Mitotane—Anaemia—Epirubicin—prostate cancer	4.78e-05	0.000354	CcSEcCtD
Mitotane—Dyspepsia—Prednisone—prostate cancer	4.75e-05	0.000352	CcSEcCtD
Mitotane—Rash—Etoposide—prostate cancer	4.75e-05	0.000352	CcSEcCtD
Mitotane—Dermatitis—Etoposide—prostate cancer	4.75e-05	0.000351	CcSEcCtD
Mitotane—Headache—Etoposide—prostate cancer	4.72e-05	0.000349	CcSEcCtD
Mitotane—Decreased appetite—Prednisone—prostate cancer	4.7e-05	0.000347	CcSEcCtD
Mitotane—Dysgeusia—Doxorubicin—prostate cancer	4.69e-05	0.000347	CcSEcCtD
Mitotane—Vertigo—Epirubicin—prostate cancer	4.65e-05	0.000344	CcSEcCtD
Mitotane—Hypersensitivity—Docetaxel—prostate cancer	4.61e-05	0.000341	CcSEcCtD
Mitotane—Vision blurred—Doxorubicin—prostate cancer	4.51e-05	0.000334	CcSEcCtD
Mitotane—Asthenia—Docetaxel—prostate cancer	4.49e-05	0.000332	CcSEcCtD
Mitotane—Nausea—Etoposide—prostate cancer	4.48e-05	0.000331	CcSEcCtD
Mitotane—Hypertension—Epirubicin—prostate cancer	4.47e-05	0.000331	CcSEcCtD
Mitotane—Hypersensitivity—Capecitabine—prostate cancer	4.47e-05	0.00033	CcSEcCtD
Mitotane—Feeling abnormal—Prednisone—prostate cancer	4.45e-05	0.000329	CcSEcCtD
Mitotane—Anaemia—Doxorubicin—prostate cancer	4.43e-05	0.000327	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	4.38e-05	0.000324	CcSEcCtD
Mitotane—Asthenia—Capecitabine—prostate cancer	4.35e-05	0.000322	CcSEcCtD
Mitotane—Vertigo—Doxorubicin—prostate cancer	4.3e-05	0.000318	CcSEcCtD
Mitotane—Diarrhoea—Docetaxel—prostate cancer	4.29e-05	0.000317	CcSEcCtD
Mitotane—Body temperature increased—Prednisone—prostate cancer	4.27e-05	0.000316	CcSEcCtD
Mitotane—Confusional state—Epirubicin—prostate cancer	4.26e-05	0.000315	CcSEcCtD
Mitotane—Infection—Epirubicin—prostate cancer	4.2e-05	0.00031	CcSEcCtD
Mitotane—Shock—Epirubicin—prostate cancer	4.16e-05	0.000307	CcSEcCtD
Mitotane—Diarrhoea—Capecitabine—prostate cancer	4.15e-05	0.000307	CcSEcCtD
Mitotane—Nervous system disorder—Epirubicin—prostate cancer	4.14e-05	0.000306	CcSEcCtD
Mitotane—Dizziness—Docetaxel—prostate cancer	4.14e-05	0.000306	CcSEcCtD
Mitotane—Thrombocytopenia—Epirubicin—prostate cancer	4.14e-05	0.000306	CcSEcCtD
Mitotane—Hypertension—Doxorubicin—prostate cancer	4.13e-05	0.000306	CcSEcCtD
Mitotane—Skin disorder—Epirubicin—prostate cancer	4.1e-05	0.000304	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	4.05e-05	0.0003	CcSEcCtD
Mitotane—Anorexia—Epirubicin—prostate cancer	4.03e-05	0.000298	CcSEcCtD
Mitotane—Dizziness—Capecitabine—prostate cancer	4.01e-05	0.000297	CcSEcCtD
Mitotane—Vomiting—Docetaxel—prostate cancer	3.98e-05	0.000295	CcSEcCtD
Mitotane—Hypersensitivity—Prednisone—prostate cancer	3.98e-05	0.000294	CcSEcCtD
Mitotane—Rash—Docetaxel—prostate cancer	3.95e-05	0.000292	CcSEcCtD
Mitotane—Hypotension—Epirubicin—prostate cancer	3.95e-05	0.000292	CcSEcCtD
Mitotane—Dermatitis—Docetaxel—prostate cancer	3.95e-05	0.000292	CcSEcCtD
Mitotane—Confusional state—Doxorubicin—prostate cancer	3.94e-05	0.000292	CcSEcCtD
Mitotane—Headache—Docetaxel—prostate cancer	3.92e-05	0.00029	CcSEcCtD
Mitotane—Infection—Doxorubicin—prostate cancer	3.88e-05	0.000287	CcSEcCtD
Mitotane—Asthenia—Prednisone—prostate cancer	3.88e-05	0.000287	CcSEcCtD
Mitotane—Vomiting—Capecitabine—prostate cancer	3.86e-05	0.000285	CcSEcCtD
Mitotane—Shock—Doxorubicin—prostate cancer	3.85e-05	0.000284	CcSEcCtD
Mitotane—Nervous system disorder—Doxorubicin—prostate cancer	3.83e-05	0.000284	CcSEcCtD
Mitotane—Thrombocytopenia—Doxorubicin—prostate cancer	3.83e-05	0.000283	CcSEcCtD
Mitotane—Rash—Capecitabine—prostate cancer	3.82e-05	0.000283	CcSEcCtD
Mitotane—Dermatitis—Capecitabine—prostate cancer	3.82e-05	0.000283	CcSEcCtD
Mitotane—Headache—Capecitabine—prostate cancer	3.8e-05	0.000281	CcSEcCtD
Mitotane—Skin disorder—Doxorubicin—prostate cancer	3.8e-05	0.000281	CcSEcCtD
Mitotane—Paraesthesia—Epirubicin—prostate cancer	3.79e-05	0.000281	CcSEcCtD
Mitotane—Somnolence—Epirubicin—prostate cancer	3.76e-05	0.000278	CcSEcCtD
Mitotane—Anorexia—Doxorubicin—prostate cancer	3.73e-05	0.000276	CcSEcCtD
Mitotane—Nausea—Docetaxel—prostate cancer	3.72e-05	0.000275	CcSEcCtD
Mitotane—Dyspepsia—Epirubicin—prostate cancer	3.72e-05	0.000275	CcSEcCtD
Mitotane—Diarrhoea—Prednisone—prostate cancer	3.7e-05	0.000273	CcSEcCtD
Mitotane—Decreased appetite—Epirubicin—prostate cancer	3.67e-05	0.000272	CcSEcCtD
Mitotane—Hypotension—Doxorubicin—prostate cancer	3.65e-05	0.00027	CcSEcCtD
Mitotane—Gastrointestinal disorder—Epirubicin—prostate cancer	3.65e-05	0.00027	CcSEcCtD
Mitotane—Pain—Epirubicin—prostate cancer	3.61e-05	0.000267	CcSEcCtD
Mitotane—Nausea—Capecitabine—prostate cancer	3.6e-05	0.000266	CcSEcCtD
Mitotane—Dizziness—Prednisone—prostate cancer	3.57e-05	0.000264	CcSEcCtD
Mitotane—Paraesthesia—Doxorubicin—prostate cancer	3.51e-05	0.00026	CcSEcCtD
Mitotane—Feeling abnormal—Epirubicin—prostate cancer	3.48e-05	0.000258	CcSEcCtD
Mitotane—Somnolence—Doxorubicin—prostate cancer	3.47e-05	0.000257	CcSEcCtD
Mitotane—Dyspepsia—Doxorubicin—prostate cancer	3.44e-05	0.000255	CcSEcCtD
Mitotane—Vomiting—Prednisone—prostate cancer	3.43e-05	0.000254	CcSEcCtD
Mitotane—Rash—Prednisone—prostate cancer	3.41e-05	0.000252	CcSEcCtD
Mitotane—Dermatitis—Prednisone—prostate cancer	3.4e-05	0.000252	CcSEcCtD
Mitotane—Decreased appetite—Doxorubicin—prostate cancer	3.4e-05	0.000251	CcSEcCtD
Mitotane—Headache—Prednisone—prostate cancer	3.38e-05	0.00025	CcSEcCtD
Mitotane—Gastrointestinal disorder—Doxorubicin—prostate cancer	3.37e-05	0.00025	CcSEcCtD
Mitotane—Pain—Doxorubicin—prostate cancer	3.34e-05	0.000247	CcSEcCtD
Mitotane—Body temperature increased—Epirubicin—prostate cancer	3.34e-05	0.000247	CcSEcCtD
Mitotane—Feeling abnormal—Doxorubicin—prostate cancer	3.22e-05	0.000238	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—MED12—prostate cancer	3.22e-05	0.000245	CbGpPWpGaD
Mitotane—Nausea—Prednisone—prostate cancer	3.21e-05	0.000237	CcSEcCtD
Mitotane—FDX1—Metabolism—GGT1—prostate cancer	3.21e-05	0.000244	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	3.2e-05	0.000243	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	3.18e-05	0.000242	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—TGFB1—prostate cancer	3.17e-05	0.000241	CbGpPWpGaD
Mitotane—FDX1—Metabolism—NCOA1—prostate cancer	3.16e-05	0.00024	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	3.15e-05	0.00024	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PGAM2—prostate cancer	3.15e-05	0.000239	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—SULT2B1—prostate cancer	3.15e-05	0.000239	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GSTM3—prostate cancer	3.15e-05	0.000239	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—AOX1—prostate cancer	3.15e-05	0.000239	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—MBTPS1—prostate cancer	3.15e-05	0.000239	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—NAGLU—prostate cancer	3.15e-05	0.000239	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—RFK—prostate cancer	3.15e-05	0.000239	CbGpPWpGaD
Mitotane—FDX1—Metabolism—CYP19A1—prostate cancer	3.11e-05	0.000237	CbGpPWpGaD
Mitotane—Hypersensitivity—Epirubicin—prostate cancer	3.11e-05	0.00023	CcSEcCtD
Mitotane—Body temperature increased—Doxorubicin—prostate cancer	3.09e-05	0.000229	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	3.07e-05	0.000234	CbGpPWpGaD
Mitotane—Asthenia—Epirubicin—prostate cancer	3.03e-05	0.000224	CcSEcCtD
Mitotane—FDX1—Metabolism—RXRA—prostate cancer	3.01e-05	0.000229	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	3e-05	0.000228	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CYP3A43—prostate cancer	2.98e-05	0.000227	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—AMACR—prostate cancer	2.98e-05	0.000227	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—SRD5A2—prostate cancer	2.98e-05	0.000227	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—NAT1—prostate cancer	2.98e-05	0.000227	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—DEGS1—prostate cancer	2.98e-05	0.000227	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—B4GALT4—prostate cancer	2.96e-05	0.000226	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—HPGD—prostate cancer	2.96e-05	0.000226	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	2.93e-05	0.000223	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.92e-05	0.000222	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—CYP2C19—prostate cancer	2.91e-05	0.000222	CbGpPWpGaD
Mitotane—FDX1—Metabolism—COMT—prostate cancer	2.9e-05	0.00022	CbGpPWpGaD
Mitotane—Diarrhoea—Epirubicin—prostate cancer	2.89e-05	0.000214	CcSEcCtD
Mitotane—FDX1—Metabolism—GSTP1—prostate cancer	2.88e-05	0.000219	CbGpPWpGaD
Mitotane—Hypersensitivity—Doxorubicin—prostate cancer	2.88e-05	0.000213	CcSEcCtD
Mitotane—CYP11A1—Metabolism—HSD17B1—prostate cancer	2.84e-05	0.000216	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	2.84e-05	0.000216	CbGpPWpGaD
Mitotane—FDX1—Metabolism—ITPR1—prostate cancer	2.84e-05	0.000216	CbGpPWpGaD
Mitotane—Asthenia—Doxorubicin—prostate cancer	2.8e-05	0.000207	CcSEcCtD
Mitotane—Dizziness—Epirubicin—prostate cancer	2.79e-05	0.000207	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.79e-05	0.000212	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—TNFRSF21—prostate cancer	2.79e-05	0.000212	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	2.74e-05	0.000208	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	2.72e-05	0.000207	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CYP7B1—prostate cancer	2.71e-05	0.000206	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—MTAP—prostate cancer	2.71e-05	0.000206	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	2.69e-05	0.000205	CbGpPWpGaD
Mitotane—Vomiting—Epirubicin—prostate cancer	2.69e-05	0.000199	CcSEcCtD
Mitotane—FDX1—Metabolism—TYMS—prostate cancer	2.68e-05	0.000204	CbGpPWpGaD
Mitotane—Diarrhoea—Doxorubicin—prostate cancer	2.67e-05	0.000198	CcSEcCtD
Mitotane—Rash—Epirubicin—prostate cancer	2.66e-05	0.000197	CcSEcCtD
Mitotane—Dermatitis—Epirubicin—prostate cancer	2.66e-05	0.000197	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	2.65e-05	0.000202	CbGpPWpGaD
Mitotane—FDX1—Metabolism—GSTM1—prostate cancer	2.65e-05	0.000201	CbGpPWpGaD
Mitotane—Headache—Epirubicin—prostate cancer	2.65e-05	0.000196	CcSEcCtD
Mitotane—CYP11B1—Metabolism—SULT1E1—prostate cancer	2.64e-05	0.000201	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—SRD5A1—prostate cancer	2.64e-05	0.000201	CbGpPWpGaD
Mitotane—FDX1—Metabolism—LPL—prostate cancer	2.6e-05	0.000198	CbGpPWpGaD
Mitotane—Dizziness—Doxorubicin—prostate cancer	2.58e-05	0.000191	CcSEcCtD
Mitotane—CYP11B1—Corticotropin-releasing hormone—AKT1—prostate cancer	2.58e-05	0.000196	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	2.57e-05	0.000195	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	2.57e-05	0.000195	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—B4GALT4—prostate cancer	2.54e-05	0.000193	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—HPGD—prostate cancer	2.54e-05	0.000193	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	2.53e-05	0.000192	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—HSD17B3—prostate cancer	2.52e-05	0.000192	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ACSL4—prostate cancer	2.52e-05	0.000192	CbGpPWpGaD
Mitotane—FDX1—Metabolism—CYP1A1—prostate cancer	2.51e-05	0.000191	CbGpPWpGaD
Mitotane—Nausea—Epirubicin—prostate cancer	2.51e-05	0.000186	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	2.49e-05	0.00019	CbGpPWpGaD
Mitotane—FDX1—Metabolism—ERCC2—prostate cancer	2.49e-05	0.000189	CbGpPWpGaD
Mitotane—Vomiting—Doxorubicin—prostate cancer	2.49e-05	0.000184	CcSEcCtD
Mitotane—Rash—Doxorubicin—prostate cancer	2.46e-05	0.000182	CcSEcCtD
Mitotane—Dermatitis—Doxorubicin—prostate cancer	2.46e-05	0.000182	CcSEcCtD
Mitotane—Headache—Doxorubicin—prostate cancer	2.45e-05	0.000181	CcSEcCtD
Mitotane—CYP11B1—Metabolism—ARG2—prostate cancer	2.42e-05	0.000184	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—UMPS—prostate cancer	2.42e-05	0.000184	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PHGDH—prostate cancer	2.42e-05	0.000184	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	2.4e-05	0.000183	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—TNFRSF21—prostate cancer	2.38e-05	0.000181	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—LDHB—prostate cancer	2.37e-05	0.00018	CbGpPWpGaD
Mitotane—FDX1—Metabolism—MTHFR—prostate cancer	2.34e-05	0.000178	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CYP3A5—prostate cancer	2.33e-05	0.000177	CbGpPWpGaD
Mitotane—Nausea—Doxorubicin—prostate cancer	2.32e-05	0.000172	CcSEcCtD
Mitotane—CYP11A1—Metabolism—CYP7B1—prostate cancer	2.32e-05	0.000176	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—MTAP—prostate cancer	2.32e-05	0.000176	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PPARA—prostate cancer	2.3e-05	0.000175	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	2.27e-05	0.000172	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—SULT1E1—prostate cancer	2.26e-05	0.000172	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—SRD5A1—prostate cancer	2.26e-05	0.000172	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PDHA1—prostate cancer	2.25e-05	0.000171	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—TCN2—prostate cancer	2.25e-05	0.000171	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GSTA3—prostate cancer	2.25e-05	0.000171	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—UCP3—prostate cancer	2.25e-05	0.000171	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—AKT1—prostate cancer	2.21e-05	0.000168	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	2.2e-05	0.000167	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	2.16e-05	0.000165	CbGpPWpGaD
Mitotane—FDX1—Metabolism—CAV1—prostate cancer	2.16e-05	0.000164	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ACSL4—prostate cancer	2.16e-05	0.000164	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—HSD17B3—prostate cancer	2.16e-05	0.000164	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—HSD3B1—prostate cancer	2.14e-05	0.000163	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—SLC22A3—prostate cancer	2.14e-05	0.000163	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	2.13e-05	0.000162	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—LPL—prostate cancer	2.08e-05	0.000158	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ARG2—prostate cancer	2.07e-05	0.000157	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PHGDH—prostate cancer	2.07e-05	0.000157	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—UMPS—prostate cancer	2.07e-05	0.000157	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.06e-05	0.000157	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	2.06e-05	0.000156	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GSTA4—prostate cancer	2.05e-05	0.000156	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—TBXAS1—prostate cancer	2.05e-05	0.000156	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—LDHB—prostate cancer	2.03e-05	0.000154	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	2.01e-05	0.000153	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GSTA2—prostate cancer	2e-05	0.000152	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CYP3A5—prostate cancer	1.99e-05	0.000151	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ABCG5—prostate cancer	1.98e-05	0.00015	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—SULT1A1—prostate cancer	1.98e-05	0.00015	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PIK3CG—prostate cancer	1.97e-05	0.00015	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GSTA1—prostate cancer	1.93e-05	0.000147	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PDHA1—prostate cancer	1.92e-05	0.000146	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—TCN2—prostate cancer	1.92e-05	0.000146	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—UCP3—prostate cancer	1.92e-05	0.000146	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GSTA3—prostate cancer	1.92e-05	0.000146	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—NAT2—prostate cancer	1.91e-05	0.000145	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GSTO1—prostate cancer	1.91e-05	0.000145	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—HSD3B2—prostate cancer	1.91e-05	0.000145	CbGpPWpGaD
Mitotane—FDX1—Metabolism—INS—prostate cancer	1.86e-05	0.000142	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	1.84e-05	0.00014	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—HSD3B1—prostate cancer	1.83e-05	0.000139	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—SLC22A3—prostate cancer	1.83e-05	0.000139	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PLCB2—prostate cancer	1.83e-05	0.000139	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CYP2C18—prostate cancer	1.83e-05	0.000139	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—LRP2—prostate cancer	1.83e-05	0.000139	CbGpPWpGaD
Mitotane—FDX1—Metabolism—CREBBP—prostate cancer	1.82e-05	0.000139	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—P4HB—prostate cancer	1.8e-05	0.000137	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—LPL—prostate cancer	1.78e-05	0.000135	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GSTA4—prostate cancer	1.76e-05	0.000134	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—TBXAS1—prostate cancer	1.76e-05	0.000134	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—SLC22A1—prostate cancer	1.75e-05	0.000133	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PIK3CD—prostate cancer	1.73e-05	0.000132	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	1.73e-05	0.000131	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	1.72e-05	0.000131	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GSTA2—prostate cancer	1.71e-05	0.00013	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—SULT2A1—prostate cancer	1.7e-05	0.00013	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ABCG5—prostate cancer	1.69e-05	0.000129	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—SULT1A1—prostate cancer	1.69e-05	0.000129	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—MED12—prostate cancer	1.67e-05	0.000127	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GNG5—prostate cancer	1.66e-05	0.000126	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GSTA1—prostate cancer	1.65e-05	0.000126	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—HSD3B2—prostate cancer	1.63e-05	0.000124	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GSTO1—prostate cancer	1.63e-05	0.000124	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—NAT2—prostate cancer	1.63e-05	0.000124	CbGpPWpGaD
Mitotane—FDX1—Metabolism—NOS3—prostate cancer	1.63e-05	0.000124	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—NCOA3—prostate cancer	1.6e-05	0.000122	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	1.57e-05	0.00012	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	1.57e-05	0.00012	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PLCB2—prostate cancer	1.57e-05	0.000119	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CYP2C18—prostate cancer	1.57e-05	0.000119	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—LRP2—prostate cancer	1.57e-05	0.000119	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—P4HB—prostate cancer	1.54e-05	0.000117	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—HPGDS—prostate cancer	1.53e-05	0.000116	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CYP2C19—prostate cancer	1.52e-05	0.000115	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PIK3CB—prostate cancer	1.51e-05	0.000115	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—SLC22A1—prostate cancer	1.49e-05	0.000114	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PTGS2—prostate cancer	1.49e-05	0.000114	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GSTT1—prostate cancer	1.48e-05	0.000113	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ACHE—prostate cancer	1.48e-05	0.000113	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	1.48e-05	0.000112	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CYP2A6—prostate cancer	1.46e-05	0.000111	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.46e-05	0.000111	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—SULT2A1—prostate cancer	1.46e-05	0.000111	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—MED12—prostate cancer	1.43e-05	0.000109	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—AKR1C3—prostate cancer	1.42e-05	0.000108	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GNG5—prostate cancer	1.42e-05	0.000108	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PRKACB—prostate cancer	1.42e-05	0.000108	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CYP17A1—prostate cancer	1.4e-05	0.000107	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.38e-05	0.000105	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—NCOA3—prostate cancer	1.37e-05	0.000104	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	1.35e-05	0.000102	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—NCOA2—prostate cancer	1.34e-05	0.000102	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—HPGDS—prostate cancer	1.31e-05	9.94e-05	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PTEN—prostate cancer	1.3e-05	9.91e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CYP2C19—prostate cancer	1.3e-05	9.88e-05	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—SLC5A5—prostate cancer	1.27e-05	9.7e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GSTT1—prostate cancer	1.27e-05	9.64e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ACHE—prostate cancer	1.27e-05	9.64e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CYP2A6—prostate cancer	1.25e-05	9.53e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.25e-05	9.49e-05	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CYP2E1—prostate cancer	1.24e-05	9.47e-05	CbGpPWpGaD
Mitotane—FDX1—Metabolism—EP300—prostate cancer	1.24e-05	9.45e-05	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—NQO1—prostate cancer	1.23e-05	9.36e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—AKR1C3—prostate cancer	1.22e-05	9.27e-05	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—TH—prostate cancer	1.21e-05	9.23e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PRKACB—prostate cancer	1.21e-05	9.22e-05	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.21e-05	9.17e-05	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CYP3A4—prostate cancer	1.2e-05	9.13e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CYP17A1—prostate cancer	1.2e-05	9.13e-05	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.19e-05	9.09e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.18e-05	9e-05	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CYP1B1—prostate cancer	1.18e-05	8.98e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—NCOA2—prostate cancer	1.14e-05	8.7e-05	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GGT1—prostate cancer	1.14e-05	8.7e-05	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—NCOA1—prostate cancer	1.13e-05	8.56e-05	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CYP19A1—prostate cancer	1.11e-05	8.44e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—SLC5A5—prostate cancer	1.09e-05	8.3e-05	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—RXRA—prostate cancer	1.07e-05	8.15e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CYP2E1—prostate cancer	1.06e-05	8.1e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—NQO1—prostate cancer	1.05e-05	8.01e-05	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.04e-05	7.92e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—TH—prostate cancer	1.04e-05	7.9e-05	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—COMT—prostate cancer	1.03e-05	7.85e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.03e-05	7.84e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CYP3A4—prostate cancer	1.03e-05	7.81e-05	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GSTP1—prostate cancer	1.03e-05	7.81e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.02e-05	7.77e-05	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ITPR1—prostate cancer	1.01e-05	7.69e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CYP1B1—prostate cancer	1.01e-05	7.68e-05	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	9.93e-06	7.56e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GGT1—prostate cancer	9.78e-06	7.44e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—NCOA1—prostate cancer	9.63e-06	7.33e-05	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—TYMS—prostate cancer	9.54e-06	7.26e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CYP19A1—prostate cancer	9.49e-06	7.22e-05	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GSTM1—prostate cancer	9.43e-06	7.18e-05	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—LPL—prostate cancer	9.26e-06	7.05e-05	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PIK3CA—prostate cancer	9.18e-06	6.99e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—RXRA—prostate cancer	9.16e-06	6.97e-05	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CYP1A1—prostate cancer	8.94e-06	6.8e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	8.91e-06	6.78e-05	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ERCC2—prostate cancer	8.87e-06	6.75e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—COMT—prostate cancer	8.82e-06	6.71e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GSTP1—prostate cancer	8.78e-06	6.68e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ITPR1—prostate cancer	8.64e-06	6.57e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	8.5e-06	6.46e-05	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—MTHFR—prostate cancer	8.34e-06	6.34e-05	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PPARA—prostate cancer	8.18e-06	6.22e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—TYMS—prostate cancer	8.16e-06	6.21e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GSTM1—prostate cancer	8.07e-06	6.14e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—LPL—prostate cancer	7.92e-06	6.03e-05	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CAV1—prostate cancer	7.69e-06	5.85e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CYP1A1—prostate cancer	7.65e-06	5.82e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ERCC2—prostate cancer	7.59e-06	5.77e-05	CbGpPWpGaD
Mitotane—FDX1—Metabolism—AKT1—prostate cancer	7.5e-06	5.71e-05	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	7.35e-06	5.59e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—MTHFR—prostate cancer	7.13e-06	5.43e-05	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PIK3CG—prostate cancer	7e-06	5.33e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PPARA—prostate cancer	7e-06	5.32e-05	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—INS—prostate cancer	6.63e-06	5.04e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CAV1—prostate cancer	6.58e-06	5.01e-05	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CREBBP—prostate cancer	6.49e-06	4.94e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	6.29e-06	4.78e-05	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PIK3CD—prostate cancer	6.16e-06	4.69e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PIK3CG—prostate cancer	5.99e-06	4.56e-05	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—NOS3—prostate cancer	5.81e-06	4.42e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—INS—prostate cancer	5.67e-06	4.32e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CREBBP—prostate cancer	5.56e-06	4.23e-05	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PIK3CB—prostate cancer	5.37e-06	4.08e-05	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PTGS2—prostate cancer	5.32e-06	4.05e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PIK3CD—prostate cancer	5.27e-06	4.01e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—NOS3—prostate cancer	4.97e-06	3.78e-05	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PTEN—prostate cancer	4.64e-06	3.53e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PIK3CB—prostate cancer	4.59e-06	3.49e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PTGS2—prostate cancer	4.55e-06	3.46e-05	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—EP300—prostate cancer	4.42e-06	3.37e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PTEN—prostate cancer	3.97e-06	3.02e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—EP300—prostate cancer	3.78e-06	2.88e-05	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PIK3CA—prostate cancer	3.27e-06	2.49e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PIK3CA—prostate cancer	2.8e-06	2.13e-05	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—AKT1—prostate cancer	2.67e-06	2.03e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—AKT1—prostate cancer	2.29e-06	1.74e-05	CbGpPWpGaD
